Assertion: tap | /r/CapableOf | withdraw its new drug application
Facets:
value: in 2000
type: TEMPORAL
value: for apomorphine
type: TRANSITIVE-OBJECT
value: due to many clinical trial subjects
type: CAUSE
value: as a treatment for erectile dysfunction
type: PURPOSE
Source sentences:
text: In 2000, TAP's withdrew its new drug application for apomorphine (branded as "Uprima") as a treatment for erectile dysfunction after an FDA review panel raised questions about the drug's safety, due to many clinical trial subjects fainting after taking the drug.